← Back to all trials
Completed
NCT05673798
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
Conditions: Small Cell Lung Cancer
Sex: All
Enrollment: 569
Sponsor: The Second Hospital of Shandong University
Summary
In this retrospective study, patients diagnosed with SCLC between January 2011 to September 2022 were identified from database of the Second Hospital of Shandong University.
Following inclusion criteria should be met: (1) Had histologically or cytologically confirmed newly diagnosed SCLC; (2) No cancer treatment has been done before; (3) Complete clinical, laboratory, imaging, treatment data and follow-up information.
The exclusion criteria included: Patients without complete records for pathological information, complete epidemiology and other key clinical information.
Eligibility Criteria
Inclusion Criteria:Newly diagnosis of small cell lung cancerNo cancer treatment has been done beforeComplete clinical, laboratory, imaging, treatment data and follow-up informationExclusion Criteria:1. Without complete records for pathological information, complete epidemiology and other key clinical information
Source: ClinicalTrials.gov (NCT05673798). StuddyBuddy aggregates publicly available trial information.